Top Story

‘Building bridges’ between PCPs, liver specialists for HCV led to 100% cure

November 14, 2019
Meeting News

‘Quest for better HDV therapy’: triple combination reduces RNA in most

November 13, 2019
BOSTON — Triple combination therapy with lonafarnib, ritonavir, and Lambda for chronic hepatitis D appeared safe and tolerable for up to 6 months in most patients…
In the Journals

EMR hard stop reduces repeat C. difficile testing

November 12, 2019
A hard stop clinical decision support tool embedded in the electronic medical record significantly reduced repeat Clostridioides difficile toxin enzyme immunoassay, or…
In the Journals

Albumin, liver stiffness after DAA therapy for HCV stratify liver cancer risk

November 8, 2019
Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients with hepatitis C and…
More Headlines »
Healio Jobs